V CompBrief BY VELARION

Independent Director · Crinetics Pharmaceuticals, Inc. (CRNX)

Caren Deardorf director compensation at Crinetics (FY2025): $485K

Fiscal year 2025 director compensation for Caren Deardorf at Crinetics Pharmaceuticals, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Caren Deardorf’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Caren Deardorf and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Crinetics Pharmaceuticals Director Compensation Table · all 2 fiscal years held
In US dollars, as Crinetics Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$59,875$223,077$202,515$0$485,467
FY2024$45,750$152,014$341,750—$539,514

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Crinetics Pharmaceuticals, Inc. DEF 14A filed April 29, 2026, accession 0001658247-26-000030, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Crinetics Pharmaceuticals, Inc. filed document, accession 0001658247-26-000030. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Get the Crinetics Pharmaceuticals Board Governance Report

$485,467 Caren Deardorf, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Committees

FY2025 · as the proxy prints them

Nominating/Governance · Global Therapeutics Strategy and Access

The rest of the Crinetics Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Camille Bedrosian, M.DIndependent Director$500,467
Matthew K. FustIndependent Director$498,592
R. Scott Struthers, Ph.DDirector—
Rogério Vivaldi Coelho, M.DIndependent Director$507,342
Stephanie S. Okey, M.SIndependent Director$500,467
Wendell Wierenga, Ph.DChair of the Board$528,617
Weston Nichols, Ph.DIndependent Director$493,844

The full Crinetics Pharmaceuticals compensation record

free company brief
Crinetics Pharmaceuticals, Inc. (CRNX) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within Crinetics Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Crinetics Pharmaceuticals proxy · each links to its own free brief

Order CRNX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report